Biotech Juggernaut: Hope, Hype, and Hidden Agendas of Entrepreneurial BioScience relates the intensifying effort of bioentrepreneurs to apply genetic engineering technologies to the human species and to extend the commercial reach of synthetic biology or "extreme genetic engineering." In 1980, legal developments concerning patenting laws transformed scientific researchers into bioentrepreneurs. Often motivated to create profit-driven biotech start-up companies or to serve on their advisory boards, university researchers now commonly operate under serious conflicts of interest. These conflicts stand in the way of giving full consideration to the social and ethical consequences of the technologies they seek to develop. Too often, bioentrepreneurs have worked to obscure how these technologies could alter human evolution and to hide the social costs of keeping on this path. Tracing the rise and cultural politics of biotechnology from a critical perspective, Biotech Juggernaut aims to correct the informational imbalance between producers of biotechnologies on the one hand, and the intended consumers of these technologies and general society, on the other. It explains how the converging vectors of economic, political, social, and cultural elements driving biotechnology’s swift advance constitutes a juggernaut. It concludes with a reflection on whether it is possible for an informed public to halt what appears to be a runaway force.

The Church’s New Front Door introduces Christians to the critically important concept of the Fourth Industrial Revolution, an era that will be dominated by powerful technologies like artificial intelligence (AI) and advanced robotics. While the Fourth Industrial Revolution is powered by technological developments, it has far-reaching political, socio-economic, ethical, and spiritual implications as well. To be missional, the church needs to be relevant; and in order to be relevant in the twenty-first century, believers must engage with novel technologies and the impact they are having on areas like work, education, and healthcare. Each chapter includes discussion questions and suggestions for further reading, making this book an accessible resource for diverse audiences, including church members, ministry leaders, and students at Christian colleges and seminaries. Whether you agree or disagree with the author’s description of how our world might change in the next ten to twenty years—this book will make you think!

Addressing the important perspectives on xenotransplantation and human embryonic stem cell research, this book explores both the enthusiastic proponents and vehement resistance to these new biomedical technologies. Investigating the political, social, and ethical forces behind this kind of research and development, as well as the commercial actors and strong financial incentives that are necessary, these stories of hope, fear, and hype are matched by stories of success, failure, and fraud, showing how these technologies have become truly polarizing.

This book provides an analysis of the ways in which the BAC has established an ethical framework for biomedical research in Singapore, following the launch of the Biomedical Sciences Initiative by the Singapore Government. The editors and authors have an intimate knowledge of the working of the BAC, and the focus of the book includes the ways in which international forces have influenced the form and substance of bioethics in Singapore. Together, the authors offer a comparative account of the institutionalisation of biomedical research ethics in Singapore, considered in the wider context of international regulatory efforts. The book reviews the work of the BAC by placing it within the broader cultural, social and political discourses that have emerged in relation to the life sciences since the turn of the 21st century. This book is not primarily intended to be a retrospect or an appraisal of the contribution of the BAC, though this is one aspect of it. Rather, the main intention is to make a substantive contribution to the rapidly emerging field of bioethics. Ethical discussions in the book include consideration of stem cell research and cloning, genetics and research with human participants, and focus on likely future developments as well as the past.Many of the contributors of the book have been personally involved in this work, and hence they write with an authoritative first-hand knowledge that scholars in bioethics and public policy may appreciate. As indicated above, the book also explains the way in which ethics and science — international and local — have interacted in a policy setting. Scholars and policy makers may find the Singaporean experience to be a valuable resource, as the approach has been to make the ethical governance of research in Singapore consistent with international best practice while observing the requirements of a properly localised application of universally accepted principles. In addition, at least three chapters (the first three chapters in particular) are accessible to the lay reader interested in the development of bioethics and biomedical sciences, both inside and outside Singapore, from 2000 (the year in which the BAC was established). Both scholars and interested lay readers are therefore likely to find this publication a valuable reference./a

In recent years the organisation and practice of collaboration in the life sciences has undergone radical transformations, owing to the advent of big science enterprises, newly developed data gathering and storage technologies, increasing levels of interdisciplinarity, and changing societal expectations for science. Collaboration in the New Life Sciences examines the causes and consequences of changing patterns of scientific collaboration in the life sciences. This book presents an understanding of how and why collaboration in the life sciences is changing and the effects of these changes on scientific knowledge, the work lives and experiences of scientists, social policy and society. Through a series of thematically arranged chapters, it considers the social, technical, and organizational facets of collaboration, addressing not only the rise of new forms of collaboration in the life sciences, but also examining recent developments in two broad research areas: ecology and environment, and the molecular life sciences. With an international team of experts presenting case studies and analyses drawn from the US, UK, Asia and Europe, Collaboration in the New Life Sciences will appeal not only to scholars and students of science and technology studies, but also to those interested in science and social policy, and the sociology of work and organisations.

William LaFleur (1936-2010), an eminent scholar of Japanese studies, left behind a substantial number of influential publications, as well as several unpublished works. The most significant of these examines debates concerning the practice of organ transplantation in Japan and the United States, and is published here for the first time. This provocative book challenges the North American medical and bioethical consensus that considers the transplantation of organs from brain dead donors as an unalloyed good. It joins a growing chorus of voices that question the assumption that brain death can be equated facilely with death. It provides a deep investigation of debates in Japan, introducing numerous Japanese bioethicists whose work has never been treated in English. It also provides a history of similar debates in the United States, problematizing the commonly held view that the American public was quick and eager to accept the redefinition of death. A work of intellectual and social history, this book also directly engages with questions that grow ever more relevant as the technologies we develop to extend life continue to advance. While the benefits of these technologies are obvious, their costs are often more difficult to articulate. Calling attention to the risks associated with our current biotech trajectory, LaFleur stakes out a highly original position that does not fall neatly onto either side of contemporary US ideological divides.

Globalization and Technocapitalism considers the global reach of a new capitalist era, exploring the nature of 'technocapitalism' as grounded in new forms of accumulation, commodification, and corporate organization. As technological creativity, corporate research, and talent flows become more important than ever, this book explores the manner in which globalization acquires new contextual features that will become central to the macro-social dynamics of the twenty-first century. It thus sheds light on the resultant growth in global inequalities and more intrusive forms of global domination that are grounded in emerging sectors, such as nanotechnology, biotechnology and its diverse fields, such as genomics, synthetic bioengineering, bioinformatics and biopharmacology, and related advances in computing and telecommunications. A rigorous examination of developments in contemporary capitalism as driven by the forces of globalization, Globalization and Technocapitalism will be of interest to scholars working in the fields of social and political theory, international political economy, political philosophy, science and technology studies and globalization.

This second edition of International Public Health Policy and Ethics complements the popular first edition with contemporary problems in international public health. It brings together philosophers and practitioners to address the foundations and principles upon which public health policy may be advanced – especially in the international arena. What is the basis that justifies public health in the first place? Why should individuals be disadvantaged for the sake of the group? How do policy concerns and clinical practice work together and work against each other? Can the boundaries of public health be extended to include social ills that are amenable to group-dynamic solutions? What about political issues? How can international finance make an impact? These are some of the crucial questions that form the core of this volume of original essays sure to cause practitioners to engage in a critical re-evaluation of the role of ethics in public health policy. With a targeted new essay dealing with COVID and public health issues in Africa this second edition provides a resource building on the first edition.

Bringing the concept of contamination into dialogue with affect theory and bioart, Agnieszka Wolodzko urges us to rethink our relationship with ourselves, each other and other organisms. Thinking through the lens of contamination, this book provides an innovative approach to understanding the leaky, porous and visceral nature of our bodies and their endless interrelationships and, in doing so, uncovers new ways for thinking about embodiment. Affect theory has long been interested in transmission or contagion but, inspired by Spinoza and Deleuze, Affect as Contamination goes further, as contamination is concerned with the materiality of bodies and their affective encounter with other matter. This brings urgency to the notion of affect, not only for bioart that works with risky bodies but also for understanding how to practise our bodies in the age of biotechnological manipulation and governance. Using challenging and transgressive bioart projects as provocative case studies for rethinking affect and bodily practice, Wolodzko follows various 'contaminants' from blood, hormones and viruses to food, glitter and plants. This takes the form of both personal accounts of encounters with the contaminations of bioart and critical analyses of aesthetic, material and technical objects, with each one highlighting in different ways the risky and uncertain nature of contamination. Affect as Contamination is an urgent and original meditation on just what it means to be living, and practising our bodies, in an era where biotechnology contaminates all aspects of our lives.

The emergence of CRISPR/Cas9 technology has revolutionized gene editing. The Nobel prize for chemistry was awarded to Emmanuelle Charpentier and Jennifer Doudna, the scientists responsible for its discovery, in 2020 and it is considered the frontier of sophisticated medical science. This technology contains the promise that both gene therapy and eugenic control of human evolution is possible, even plausible, in our near future. This book looks at these developements in the context of the history of previous social and scientific attempts at genetic editing, and explores the policy and ethical challenges they raise. It presents the case for altering the human germ-line (which contains and controls hereditary genetic information) to eliminate a large number of genetic diseases controlled by a single or few genes, while pointing out that gene therapy is likely to be ineffective for diseases with more complex causes. In parallel it explores the possibility of genetic enhancement in a set of case studies. But it also argues that, in general, genetic enhancement is ethically problematic and should be approached with caution. Given the success of CRISPR/Cas9 gene editing, and the explosion of related techniques, in practice it would be virtually impossible to ban germ-line editing in our future. A more useful goal is to put regulation in place, with oversight that represents the interests of society. That, in turn, requires an informed public discussion of these issues, which is the intention of this book.